药代动力学-话题@MedSci

#药代动力学#

48篇内容 | 2822人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1351282, encodeId=ce3c13512824a, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Biomed Chromatogr：知柏草煎剂口服后八种生物活性成分的药代动力学研究及临床疗效观察, objectType=article, longId=197209, objectId=9f5919e209b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f5919e209b8, replyNumber=0, likeNumber=84, createdTime=2020-07-09, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f5919e209b8, moduleTitle=Biomed Chromatogr：知柏草煎剂口服后八种生物活性成分的药代动力学研究及临床疗效观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f5919e209b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351281, encodeId=01e013512814f, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Andrology：一代磷酸二酯酶5抑制剂及其药代动力学问题, objectType=article, longId=192978, objectId=ed8c1929e84e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed8c1929e84e, replyNumber=0, likeNumber=86, createdTime=2020-04-27, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed8c1929e84e, moduleTitle=Andrology：一代磷酸二酯酶5抑制剂及其药代动力学问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed8c1929e84e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351280, encodeId=5d441351280f3, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性, objectType=article, longId=192727, objectId=297f192e2779, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=297f192e2779, replyNumber=0, likeNumber=88, createdTime=2020-04-23, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=297f192e2779, moduleTitle=Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=297f192e2779)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351279, encodeId=9cca13512e994, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Respir Investig：贝达喹啉在日本耐肺多药结核病患者中的安全性，有效性和药代动力学, objectType=article, longId=192368, objectId=f90c192368f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f90c192368f9, replyNumber=0, likeNumber=78, createdTime=2020-04-17, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f90c192368f9, moduleTitle=Respir Investig：贝达喹啉在日本耐肺多药结核病患者中的安全性，有效性和药代动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f90c192368f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351278, encodeId=7fa213512e882, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=AP&T：二甲双胍在慢性肝病患者中的安全性和药代动力学, objectType=article, longId=188221, objectId=2cdc188221b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cdc188221b6, replyNumber=0, likeNumber=106, createdTime=2020-02-18, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cdc188221b6, moduleTitle=AP&T：二甲双胍在慢性肝病患者中的安全性和药代动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cdc188221b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351277, encodeId=5be013512e7e1, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=FDA拟修订群体药代动力学指南：医药商需要了解些什么？, objectType=article, longId=181184, objectId=d20a18118420, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d20a18118420, replyNumber=0, likeNumber=91, createdTime=2019-10-16, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d20a18118420, moduleTitle=FDA拟修订群体药代动力学指南：医药商需要了解些什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d20a18118420)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351276, encodeId=e9d813512e656, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=门诊儿科患者通过鼻腔给予右美托咪定的药代动力学及镇静作用研究, objectType=article, longId=178516, objectId=b2091e85169a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2091e85169a, replyNumber=0, likeNumber=85, createdTime=2019-09-02, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2091e85169a, moduleTitle=门诊儿科患者通过鼻腔给予右美托咪定的药代动力学及镇静作用研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2091e85169a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351275, encodeId=d53613512e596, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Blood：VWF清除和FVIII结合的遗传决定因素修饰血友病患者的FVIII药代动力学, objectType=article, longId=176471, objectId=7c801e6471c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c801e6471c5, replyNumber=0, likeNumber=94, createdTime=2019-07-31, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c801e6471c5, moduleTitle=Blood：VWF清除和FVIII结合的遗传决定因素修饰血友病患者的FVIII药代动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c801e6471c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351274, encodeId=3e3413512e488, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Clin Chem：偶尔和长期吸食大麻者模拟驾驶对警惕性和事故风险的影响及其药代动力学-药效学关系, objectType=article, longId=175893, objectId=0c821e5893d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c821e5893d6, replyNumber=0, likeNumber=83, createdTime=2019-07-23, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c821e5893d6, moduleTitle=Clin Chem：偶尔和长期吸食大麻者模拟驾驶对警惕性和事故风险的影响及其药代动力学-药效学关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c821e5893d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351273, encodeId=722a13512e33a, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Clin Gastroenterology H：英夫利昔单抗和硫唑嘌呤联合治疗可改善英夫利昔单药代动力学特征和疗效, objectType=article, longId=175464, objectId=2f6d1e546456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f6d1e546456, replyNumber=0, likeNumber=61, createdTime=2019-07-16, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f6d1e546456, moduleTitle=Clin Gastroenterology H：英夫利昔单抗和硫唑嘌呤联合治疗可改善英夫利昔单药代动力学特征和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f6d1e546456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351272, encodeId=f1b713512e282, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=JCLA：应用电化学发光法定量测定抗分形多胺单克隆抗体E6011在猴子和人类体内的药代动力学研究, objectType=article, longId=166239, objectId=a52d16623913, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a52d16623913, replyNumber=0, likeNumber=65, createdTime=2019-05-18, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a52d16623913, moduleTitle=JCLA：应用电化学发光法定量测定抗分形多胺单克隆抗体E6011在猴子和人类体内的药代动力学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a52d16623913)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351271, encodeId=1d1213512e1e1, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=尼古丁和烟草研究协会（SRNT）年会：I / II期试验阐明了Cytisinicline的多剂量、药代动力学和药效学特征, objectType=article, longId=161124, objectId=282916112457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=282916112457, replyNumber=0, likeNumber=96, createdTime=2019-02-27, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=282916112457, moduleTitle=尼古丁和烟草研究协会（SRNT）年会：I / II期试验阐明了Cytisinicline的多剂量、药代动力学和药效学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=282916112457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351270, encodeId=1a6813512e072, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Diabetic Med：钠-葡萄糖共转运蛋白-2抑制剂依帕列净在2型糖尿病年轻人中的药代动力学和药效学特征, objectType=article, longId=152526, objectId=ad2715252671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad2715252671, replyNumber=0, likeNumber=71, createdTime=2018-11-03, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad2715252671, moduleTitle=Diabetic Med：钠-葡萄糖共转运蛋白-2抑制剂依帕列净在2型糖尿病年轻人中的药代动力学和药效学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad2715252671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351269, encodeId=0d6d13512697d, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Ra Pharma宣布Zilucoplan在肾功能不全患者中的药代动力学结果, objectType=article, longId=149962, objectId=b17c149962ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b17c149962ab, replyNumber=0, likeNumber=70, createdTime=2018-09-30, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b17c149962ab, moduleTitle=Ra Pharma宣布Zilucoplan在肾功能不全患者中的药代动力学结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b17c149962ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351268, encodeId=d21913512683a, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=抗菌药物药代动力学/药效学理论临床应用专家共识, objectType=article, longId=141580, objectId=c267141580eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c267141580eb, replyNumber=0, likeNumber=50, createdTime=2018-06-26, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c267141580eb, moduleTitle=抗菌药物药代动力学/药效学理论临床应用专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c267141580eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351267, encodeId=fbca135126ef6, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Bone Joint J：硫酸钙载万古霉素的体外药代动力学研究, objectType=article, longId=134850, objectId=70c3134850f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70c3134850f1, replyNumber=0, likeNumber=60, createdTime=2018-04-12, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70c3134850f1, moduleTitle=Bone Joint J：硫酸钙载万古霉素的体外药代动力学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70c3134850f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351266, encodeId=45a413512665f, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Chest：四种静脉维生素C给药方案在危重症患者的药代动力学分析, objectType=article, longId=131724, objectId=e2dc131e24ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2dc131e24ed, replyNumber=0, likeNumber=69, createdTime=2018-03-09, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2dc131e24ed, moduleTitle=Chest：四种静脉维生素C给药方案在危重症患者的药代动力学分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2dc131e24ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351265, encodeId=b56b1351265d9, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=CLIN CANCER RES：恩杂鲁胺对卡巴他赛药代动力学的影响, objectType=article, longId=130594, objectId=e35a13059432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e35a13059432, replyNumber=0, likeNumber=70, createdTime=2018-02-27, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e35a13059432, moduleTitle=CLIN CANCER RES：恩杂鲁胺对卡巴他赛药代动力学的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e35a13059432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351264, encodeId=32c9135126493, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=Crit Care：美罗培南在脓毒症患者持续低效透析中的药代动力学研究！, objectType=article, longId=129120, objectId=282b129120f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=282b129120f4, replyNumber=0, likeNumber=64, createdTime=2018-02-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=282b129120f4, moduleTitle=Crit Care：美罗培南在脓毒症患者持续低效透析中的药代动力学研究！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=282b129120f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351263, encodeId=1e341351263d5, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, objectTitle=PLOS Medicine: Fc修饰的HIV-1人单克隆抗体-VRC01LS的安全性和药代动力学研究, objectType=article, longId=128453, objectId=eaad128453cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaad128453cc, replyNumber=0, likeNumber=79, createdTime=2018-02-02, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaad128453cc, moduleTitle=PLOS Medicine: Fc修饰的HIV-1人单克隆抗体-VRC01LS的安全性和药代动力学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaad128453cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药代动力学

2020-05-29

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Biomed Chromatogr：知柏草煎剂口服后八种生物活性成分的药代动力学研究及临床疗效观察

2020-07-09

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Andrology：一代磷酸二酯酶5抑制剂及其药代动力学问题

2020-04-27

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性

2020-04-23

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Respir Investig：贝达喹啉在日本耐肺多药结核病患者中的安全性，有效性和药代动力学

2020-04-17

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

AP&T：二甲双胍在慢性肝病患者中的安全性和药代动力学

2020-02-18

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

FDA拟修订群体药代动力学指南：医药商需要了解些什么？

2019-10-16

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

门诊儿科患者通过鼻腔给予右美托咪定的药代动力学及镇静作用研究

2019-09-02

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Blood：VWF清除和FVIII结合的遗传决定因素修饰血友病患者的FVIII药代动力学

2019-07-31

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Clin Chem：偶尔和长期吸食大麻者模拟驾驶对警惕性和事故风险的影响及其药代动力学-药效学关系

2019-07-23

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Clin Gastroenterology H：英夫利昔单抗和硫唑嘌呤联合治疗可改善英夫利昔单药代动力学特征和疗效

2019-07-16

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

JCLA：应用电化学发光法定量测定抗分形多胺单克隆抗体E6011在猴子和人类体内的药代动力学研究

2019-05-18

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

尼古丁和烟草研究协会（SRNT）年会：I / II期试验阐明了Cytisinicline的多剂量、药代动力学和药效学特征

2019-02-27

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Diabetic Med：钠-葡萄糖共转运蛋白-2抑制剂依帕列净在2型糖尿病年轻人中的药代动力学和药效学特征

2018-11-03

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Ra Pharma宣布Zilucoplan在肾功能不全患者中的药代动力学结果

2018-09-30

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

抗菌药物药代动力学/药效学理论临床应用专家共识

2018-06-26

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Bone Joint J：硫酸钙载万古霉素的体外药代动力学研究

2018-04-12

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Chest：四种静脉维生素C给药方案在危重症患者的药代动力学分析

2018-03-09

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

CLIN CANCER RES：恩杂鲁胺对卡巴他赛药代动力学的影响

2018-02-27

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

Crit Care：美罗培南在脓毒症患者持续低效透析中的药代动力学研究！

2018-02-08

zhaojie88 (审核中...)

前往app查看评论内容

#药代动力学#

PLOS Medicine: Fc修饰的HIV-1人单克隆抗体-VRC01LS的安全性和药代动力学研究

2018-02-02

科室
- - 订阅+
  - 更多科室
工具
服务